This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Published: September 21, 2022

;

Using data from the Taiwan National Health Insurance Research Database, Cheng-Yi Huang, MD, explains how he and Su-Chen Fang, PhD, and Yu-Hsuan Joni Shao, PhD, compared long-term effectiveness of switching to long-acting injectable antipsychotics versus remaining on oral antipsychotics. 

Read the Full Article

Watch the Mandarin version.